Molecular Partners AG (LON:0QXX)
London · Delayed Price · Currency is GBP · Price in CHF 2.900
+0.065 (2.29%)
At close: Aug 11, 2025
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 88.78 million as of August 15, 2025. Its market cap has decreased by -45.78% in one year.
Market Cap
88.78M
Enterprise Value
-28.93M
Revenue
1.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.90
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 277.60M to 88.78M, a decrease of -68.02%. That is a compound annual growth rate of -10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 88.78M | -32.67% |
| Dec 30, 2024 | 131.86M | 25.14% |
| Dec 29, 2023 | 105.37M | -41.44% |
| Dec 30, 2022 | 179.94M | -61.42% |
| Dec 30, 2021 | 466.39M | -7.36% |
| Dec 30, 2020 | 503.42M | 69.68% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.46B |
| GSK plc | 57.85B |
| Haleon | 32.21B |
| Smith & Nephew | 11.76B |
| ConvaTec Group | 4.64B |
| Hikma Pharmaceuticals | 3.95B |
| Oxford Nanopore Technologies | 2.11B |
| HUTCHMED (China) | 1.92B |